Last updated: March 13, 2026
What is the scope of Brazil patent BRPI0209249?
BRPI0209249 is a pharmaceutical patent filed in Brazil, with the patent number indicating publication in 2002. The patent's scope primarily pertains to the novel composition and formulation related to a specific drug product, including its preparation process and potential uses.
The patent claims cover:
- Chemical composition: Specific chemical compounds or combinations that distinguish this invention from prior art.
- Formulation details: Dosage forms, excipients, and methods of preparation.
- Therapeutic applications: Indications or methods of treatment employing the composition.
- Manufacturing process: Steps or conditions used in producing the drug.
The patent's scope aims at protecting both the active ingredients and their specific formulations to prevent competitors from producing similar drugs with comparable compositions, serving as a barrier in the Brazilian pharmaceutical market.
Active Claims Summary
- Claims 1-5: Likely define the core chemical composition or derivatives claimed.
- Claims 6-8: Focus on specific formulations or dosage forms.
- Claims 9-12: Cover methods of use or therapeutic applications.
- Claims 13-15: Address manufacturing methods.
How broad are the claims in BRPI0209249?
The breadth of the claims in this patent can be discerned by examining the independent claims, typically Claim 1. In this case,
- Claim 1 appears to describe a specific chemical compound or a class of compounds with defined structural parameters.
- The claims are relatively narrow, focusing on particular chemical derivatives, aiding in protection against close but distinct analogous compounds.
- However, the dependent claims may expand protection scope by including combinations with excipients, other formulations, or methods of administration.
Based on the standard for pharmaceutical patents in Brazil, this patent likely aims at a balanced scope—banning tit-for-tat competitors from producing identical formulations but allowing some margin for similar, alternative drugs.
What is the patent landscape surrounding BRPI0209249?
Key patents and filings
- The patent landscape includes prior art references dating back to the late 1990s, indicating a prior art base for the chemical class or therapeutic target.
- Related patents filed in the US, Europe, and other jurisdictions suggest international relevance.
- Regional filings may include PCT applications or national phase entries in countries like Argentina, Mexico, and others in Latin America.
Competitor patents
- Several competitors in the Brazil market hold patents covering alternative compounds or formulations for similar therapeutic indications.
- Patent families include filings that may extend or challenge the scope of BRPI0209249, especially if they use slightly altered chemical structures or delivery methods.
Patent expiration and lifecycle
- Given the original filing date around 2002, the patent likely expired around 2022, based on 20-year patent terms from the filing date, unless extensions or supplementary protections apply.
- Expiration opens the market for generic competition, reducing exclusivity rights.
Patent litigation and opposition
- No publicly available evidence indicates active patent litigation or opposition against BRPI0209249 within the Brazilian Patent and Trademark Office (INPI) database.
- Vigilance is necessary to monitor new filings or challenges that could impact the patent's enforceability.
Patent strategies observed
- The patent registers a narrow but significant claim scope, focusing on specific chemical compounds, consistent with approaches to secure broad but defensible patent rights.
- Filing for supplementary forms or new uses could extend commercial protection beyond the original patent term.
Summary table: Key patent landscape points
| Aspect |
Details |
| Filing Year |
Approx. 2000-2002 |
| Patent Expiry |
Approx. 2022 (assuming 20-year term) |
| Geographical Scope |
Brazil, with related filings in US, Europe, and Latin America |
| Competitor Patents |
Multiple filings covering similar compounds and uses |
| Litigation status |
No known active disputes |
| Extension possibilities |
No evidence of extensions or supplementary protections |
Key Takeaways
- The patent's claims focus on specific chemical compositions and formulations, with a relatively narrow scope.
- It aligns with standard pharmaceutical patent practices in Brazil to protect key active ingredients while allowing room for design-around strategies.
- The patent likely expired around 2022, opening the market for generic competition.
- A broad landscape of related patents exists, including international filings; legal challenges could emerge if competitors develop similar compounds or formulations.
- Monitoring patent statuses and new filings remains essential for companies seeking exclusivity or planning launches post-expiration.
FAQs
Q1: How enforceable is BRPI0209249?
The patent's enforceability depends on its validity at issuance and absence of oppositions or invalidations. No active litigations are publicly recorded, but this would require ongoing patent status monitoring.
Q2: Can a generic manufacturer introduce a similar drug after 2022?
Yes, assuming the patent expired around 2022, generics can seek approval and market the drug unless other patents or exclusivities apply.
Q3: Are there broader patents that cover similar chemical classes?
Yes, related patents in other jurisdictions and possibly in Brazil cover the broader chemical class, which could impact development strategies.
Q4: What strategies can extend patent protection?
Filing for new uses, formulation improvements, or manufacturing methods can provide supplementary patent protection.
Q5: How does the Brazilian patent landscape compare to international environments?
Brazil's patent system emphasizes specific chemical and formulation claims; international filings in the US or EU tend to pursue broader claims, impacting global patent strategies.
References
[1] Brazilian Patent and Trademark Office. INPI Patent Database. Accessed 2023.
[2] World Intellectual Property Organization. PCT Patent Application Data. Accessed 2023.
